A missense mutation in the sheep MC4R gene, enriched in year-round estrus breeds, boosted receptor signaling and ...
A Genome Medicine study finds differential expression outperforms allele-specific analysis for most genes, while CRISPR ...
To prevent the spread of dangerous diseases by mosquitoes, scientists have long studied their reproductive mechanisms to ...
Scientists have discovered that a “fruitless” gene in the species is responsible for the male’s ability to locate and mate ...
MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage genetic medicines company, today announced the Company will exhibit three posters at the European Society of Gene and Cell ...
MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage genetic medicines company, today announced the Company will exhibit three posters ...
Approval under the EU Clinical Trials Regulation builds on CAMP4’s recent clearances in the United Kingdom, Australia, and Argentina to initiate the Company’s global Phase 1/2 trial of CMP-002 Company ...
Single-dose CLD-401 induced tumor regression and complete response in 80% of mice in EMT6 breast tumor model Building on the growing clinical evidence supporting T-cell engagers in solid tumors, data ...
What changes after ESMO 2026 in lung oncology? Explore DeLLphi-305, Krascendo 1, SAFFRON, SANOVO, ADC advances and key negative trials.
Addition continues to progress a novel pipeline of non-viral, LNP-delivered, RNA-only gene-addition therapies for severe, lifelong genetic and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results